Immuneering Corporation - Class A — Quarterly Financial Data (NASDAQ:IMRX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Nachrichten

Immuneering (IMRX): Chief Business Officer kauft Aktien für 24.990 US-Dollar

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Immuneering: Direktor Schall kauft Aktien im Wert von 101.000 US-Dollar

Insider-Kauf bei Immuneering: Director Feinberg erwirbt Aktien für 86.904 $

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%

Alibaba, Costco among market cap stock movers on Thursday

Costco, Alibaba among market cap stock movers on Thursday

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Acrivon Therapeutics (NASDAQ:ACRV), Cormedix (NASDAQ:CRMD)

Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings - Acrivon Therapeutics (NASDAQ:ACRV), Acuity (NYSE:AYI)

Why Is Immuneering Stock Trading Lower Today? - Immuneering (NASDAQ:IMRX)

Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)